407 related articles for article (PubMed ID: 22895807)
1. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
[TBL] [Abstract][Full Text] [Related]
2. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
[TBL] [Abstract][Full Text] [Related]
3. Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.
Skriver MV; Støvring H; Kristensen JK; Charles M; Sandbæk A
Diabetologia; 2012 Sep; 55(9):2361-70. PubMed ID: 22736395
[TBL] [Abstract][Full Text] [Related]
4. Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes.
Yu D; Simmons D
Diabet Med; 2013 Dec; 30(12):1407-11. PubMed ID: 23692400
[TBL] [Abstract][Full Text] [Related]
5. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
Xu L; Chan WM; Hui YF; Lam TH
Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the risk of stroke and HbA(1c) among diabetic patients.
Zhao W; Katzmarzyk PT; Horswell R; Wang Y; Johnson J; Hu G
Diabetologia; 2014 May; 57(5):918-26. PubMed ID: 24577725
[TBL] [Abstract][Full Text] [Related]
7. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
8. Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group.
Govan L; Wu O; Briggs A; Colhoun HM; Fischbacher CM; Leese GP; McKnight JA; Philip S; Sattar N; Wild SH; Lindsay RS;
Diabetes Care; 2011 Sep; 34(9):1992-7. PubMed ID: 21788623
[TBL] [Abstract][Full Text] [Related]
9. Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry.
Camafort M; Alvarez-Rodríguez LR; Muñoz-Torrero JF; Sahuquillo JC; López-Jiménez L; Coll R; Monreal M;
Diabet Med; 2011 Jan; 28(1):73-80. PubMed ID: 21166848
[TBL] [Abstract][Full Text] [Related]
10. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
[TBL] [Abstract][Full Text] [Related]
11. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY
Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
Pickup JC; Freeman SC; Sutton AJ
BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register.
Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Zethelius B; Cederholm J;
Diabetologia; 2011 Oct; 54(10):2544-51. PubMed ID: 21674176
[TBL] [Abstract][Full Text] [Related]
14. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
Boot M; Volkening LK; Butler DA; Laffel LM
Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
[TBL] [Abstract][Full Text] [Related]
15. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
18. Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis.
Erqou S; Lee CT; Suffoletto M; Echouffo-Tcheugui JB; de Boer RA; van Melle JP; Adler AI
Eur J Heart Fail; 2013 Feb; 15(2):185-93. PubMed ID: 23099356
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
[TBL] [Abstract][Full Text] [Related]
20. The association between BMI and hospitalization for heart failure in 83,021 persons with Type 2 diabetes: a population-based study from the Swedish National Diabetes Registry.
Glogner S; Rosengren A; Olsson M; Gudbjörnsdottir S; Svensson AM; Lind M
Diabet Med; 2014 May; 31(5):586-94. PubMed ID: 24147878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
